Maybe because I am older this company that has developed a very promising drug for treatment of a large prostate looks very good to me. But also to others. All these medical development companies are high risk vs potential high reward. It just takes their lead drug to fail FDA approval for price collapse so suggest you stay with a small investment if you buy...
NYMX seems forming a nice flag formation. We discussed an intraday long opportunity on Thursday trading-room. Now we are keeping it in our watch list for potential long if it breaks above $4.50 * Trade Criteria * Date first found- April 10, 2017 Pattern/Why- Potential Flag formation Entry Target Criteria- Break of $4.50 Exit Target Criteria- N/A Stop Loss...
NYMX has reached the previous ranging area after the last drop. MACD is in oversold with a potential hidden bullish divergence. I'm expecting a bounce at least to the upper dotted line.